# Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy

> **NCT03689556** · — · UNKNOWN · sponsor: **Shanghai Proton and Heavy Ion Center** · enrollment: 40 (estimated)

## Conditions studied

- Recurrent Nasopharyngeal Carcinoma

## Interventions

- **DIAGNOSTIC_TEST:** FLT PET/CT

## Key facts

- **NCT ID:** NCT03689556
- **Lead sponsor:** Shanghai Proton and Heavy Ion Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-07
- **Primary completion:** 2023-08
- **Final completion:** 2024-08
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2020-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03689556

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03689556, "Examine the Prognostic Role of FLT PET/CT for Patients With LR-NPC Treated by Carbon Ion Therapy". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03689556. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*